Wilhelm Frolke

Title: The Innovative Contributions of Wilhelm Frolke

Introduction

Wilhelm Frolke, an accomplished inventor based in Ingelheim am Rhein, Germany, has made significant strides in the field of pharmaceuticals with his innovative ideas. With a total of two patents to his name, Frolke's work focuses on developing groundbreaking treatments for diseases such as senile dementia and obesity.

Latest Patents

Frolke's latest inventions include:

1. **1,2,4-Triazolo-Carbamates**: This innovative formulation contains new 1,2,4-triazolo-carbamates of a general formula wherein specific groups provide acetylcholinesterase inhibitors. These compounds show promise as potential drugs for the treatment of senile dementia.

2. **Lipolytic Composition and Method of Treating Obesity**: This patent outlines a lipolytic pharmaceutical composition that includes 1-(4-hydroxy-3-dimethylamino-sulfonamidophenyl)-1-hydroxy-2-(1-phenoxy-iso propylamino)ethane or its pharmaceutically acceptable acid addition salt. This composition is aimed at combating obesity effectively.

Career Highlights

Frolke is currently associated with Boehringer Ingelheim KG, a prominent player in the pharmaceutical industry. His role contributes to the company's reputation for developing innovative medical solutions that address critical health challenges.

Collaborations

Throughout his career, Wilhelm Frolke has worked alongside notable colleagues such as Karl-Heinz Weber and Dieter Hinzen. These collaborations emphasize the importance of teamwork in the pursuit of innovation and advancing pharmaceutical research.

Conclusion

Wilhelm Frolke's dedication to innovation in the pharmaceutical sector is evident through his patents and professional collaborations. His contributions, particularly in developing treatments for senile dementia and obesity, reflect the significant impact inventors can have on healthcare and society as a whole.